Santhera Pharmaceuticals Holding AG (SWX:SANN)
Switzerland · Delayed Price · Currency is CHF 13.54
-0.14 (-1.02%)
Aug 14, 2025, 5:31 PM CET
Santhera Pharmaceuticals Holding AG Employees
Santhera Pharmaceuticals Holding AG had 79 employees as of December 31, 2024. The number of employees increased by 34 or 75.22% compared to the previous year.
Employees
79
Change (1Y)
34
Growth (1Y)
75.22%
Revenue / Employee
495.15K CHF
Profits / Employee
-531.32K CHF
Market Cap
174.28M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 79 | 34 | 75.22% |
| Dec 31, 2023 | 45 | -1 | -2.18% |
| Dec 31, 2022 | 46 | 6 | 16.24% |
| Dec 31, 2021 | 39 | -47 | -54.19% |
| Dec 31, 2020 | 86 | -27 | -23.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Roche Holding AG | 103,249 |
| Novartis AG | 75,883 |
| Lonza Group AG | 18,944 |
| Alcon | 25,599 |
| Galderma Group AG | 6,545 |
| Sandoz Group AG | 22,049 |
| Straumann Holding AG | 11,815 |
| Sonova Holding AG | 18,366 |
Santhera Pharmaceuticals Holding AG News
- 3 months ago - Santhera Pharmaceuticals reports FY results - Seeking Alpha
- 5 months ago - Santhera Pharmaceuticals reports FY results - Seeking Alpha
- 7 months ago - Santhera Pharmaceuticals Provides Update on Royalty Agreement for AGAMREE® (Vamorolone) and Warrants held by Idorsia - GlobeNewsWire
- 7 months ago - Santhera Enters into Supply and Distribution Agreement for AGAMREE® (Vamorolone) with Clinigen Group - GlobeNewsWire
- 8 months ago - Santhera Announces Approval from China's NMPA for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy - Benzinga
- 11 months ago - Santhera Pharmaceuticals reports 1H results - Seeking Alpha
- 1 year ago - Santhera Enters into an Exclusive Distribution Agreement with GENESIS Pharma for AGAMREE® (Vamorolone) in Central and Eastern Europe - GlobeNewsWire